|
HS Code |
327761 |
| Chemical Name | Pentahydroxy Tryptophan |
| Molecular Formula | C11H12N2O7 |
| Molecular Weight | 284.23 g/mol |
| Appearance | White to off-white powder |
| Solubility | Soluble in water |
| Melting Point | Decomposes above 200°C |
| Cas Number | NA |
| Functional Groups | Hydroxyl, indole, amino acid |
| Structural Class | Modified tryptophan derivative |
| Stability | Stable under recommended storage conditions |
| Storage Conditions | Store at 2-8°C, protected from light and moisture |
| Iupac Name | 2-amino-3-(2,3,4,5,6-pentahydroxy-1H-indol-1-yl)propanoic acid |
| Optical Activity | Chiral, exists as L and D isomers |
| Synonyms | 5,6,7,8,9-Pentahydroxytryptophan |
| Source | Synthetic or potentially biotechnological production |
As an accredited Pentahydroxy Tryptophan factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Opaque amber glass bottle, securely sealed, labeled "Pentahydroxy Tryptophan, 25g," with hazard symbols and handling instructions. |
| Shipping | Pentahydroxy Tryptophan should be shipped in tightly sealed containers, protected from moisture and light. Package in compliance with local and international regulations for laboratory chemicals. Use appropriate cushioning and secondary containment to prevent leaks. Clearly label all packages with the chemical name, hazard information, and handling instructions to ensure safe and compliant transportation. |
| Storage | Pentahydroxy Tryptophan should be stored in a tightly sealed container, away from moisture and direct sunlight, in a cool, dry, and well-ventilated area. It should be kept at room temperature or refrigerated if recommended by the supplier. Ensure the storage area is free from incompatible substances, such as strong oxidizers. Proper labeling and access restriction are advised to maintain safety. |
Competitive Pentahydroxy Tryptophan prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615365186327 or mail to sales3@ascent-chem.com.
We will respond to you as soon as possible.
Tel: +8615365186327
Email: sales3@ascent-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Every day, at our production facility, teams dedicate themselves to refining Pentahydroxy Tryptophan. The process demands attention to molecular purity and consistency, born out of an understanding of how this compound fits the practical realities of research and manufacturing. Pentahydroxy Tryptophan stands apart from its relatives on the tryptophan spectrum, not simply for an extra hydroxyl group, but because of what that additional functionality delivers in biological and industrial applications. Those interested in innovative actives often seek more nuanced modulation of molecular behavior—this is where our experience with Pentahydroxy Tryptophan makes a difference.
We produce Pentahydroxy Tryptophan under the model number PHTP-051M, reflecting the controlled environment and batch-tracking we follow to ensure quality. Consistent particle size and verified content sit at the core of every kilogram that leaves our site. The chemistry is straightforward, yet nuanced: five hydroxyl groups attached to the tryptophan core create a unique blend of hydrophilicity and reactivity. Analysts in our in-house labs run HPLC and NMR checks against every lot, and our drying rooms deliver moisture control suited for reliable storage. This approach rules out surprises down the line—a priority shared by researchers and production engineers alike.
Purity is always a concern with modified amino acids. Users ask for reliable batches with minimal byproduct drift, because bioassay results are only as good as the starting material. We standardized our purification protocols so that purity routinely stands at 98% or higher, supported by certificate of analysis from each batch. Granulation comes from years of hands-on experience with filtration and crystallization, allowing for easy dissolution in research applications. Stability testing in real-world storage conditions remains ongoing—feedback cycles between production and R&D floors let us improve small details, sometimes as simple as adjusting the final drying step or container sealant.
Those who work in the realm of advanced biochemistry often ask how Pentahydroxy Tryptophan measures up next to more familiar amino acid analogues. The main difference lies in its expanded reactivity. With five hydroxyls, the molecule supports a broader array of coupling and tagging reactions. This property hasn’t gone unnoticed by researchers chasing innovative conjugates or functionalized peptides. In peptide synthesis, for example, our customers notice improved yields with certain sequences, and superior stability in some solution-phase reactions.
Standard tryptophan or its monosubstituted forms have found their limits in contexts where electron-donating effects or increased solubility are not just desired, but required. Our Pentahydroxy version, through direct feedback from academic and industrial labs, closes several of those functional gaps. We’ve repeatedly seen research projects turn up more reliable data thanks to the minimized impurity backdrop and enhanced reactivity. Our technical support team often works shoulder-to-shoulder with users to refine protocols, especially in areas where previous amino acid analogues fell short—oxidative stability and reactivity with electrophilic agents, to name two common examples.
In peptide chemistry, researchers pursue tighter control over side-chain modifications and labeling, so the compound’s versatility takes center stage. We’ve supplied Pentahydroxy Tryptophan to teams focusing on fluorescent tagging and coupling in aqueous systems, where traditional hydrophobic amino acid derivatives lagged. In some cases, this has led to more intense label integration, streamlined cleanup, and an overall bounce in process efficiency.
We talk less about theoretical versatility and more about what happens on the bench. Recently, a biotechnology group came to us after frustration with low-yielding reactions using monohydroxylated analogues in their peptide labeling experiments. After switching to our Pentahydroxy Tryptophan, recovery rates improved, and downstream analytics simplified. No single compound delivers a universal fix, but the unique profile here suits these challenges—and this story plays out again and again in process optimization meetings across different industry segments.
Enzyme inhibitor studies benefit from the increased polarity and functional flexibility as well. It becomes easier to tune interactions, thanks to the way Pentahydroxy Tryptophan influences hydrogen bonding and stacking with target sites. Rather than wrestling with unpredictable solvation or aggregation artifacts, labs report more reproducible data, even across different solvent systems. That reliability powers better model development, particularly for those in the biopharma pipeline.
We also see demand from the polymer and advanced materials community. Pentahydroxy Tryptophan’s structure allows for grafting onto synthetic scaffolds, opening new frontiers for biocompatibility testing. The compound’s hydrophilicity gives formulators a route to increase water dispersibility without introducing charged groups. For researchers in membrane science or coatings, the difference comes through in process speed—avoiding additional surfactants and modifiers saves costs and minimizes secondary waste streams.
Functionality in cosmetics and topical actives remains a fast-evolving field. Modified tryptophans have long histories in skincare pipelines, but Pentahydroxy Tryptophan’s solubility in both water and certain oils brings a new set of formulation choices. Small-batch cosmetic manufacturers have approached us for technical guidance, noticing smoother emulsions and more stable blends in preliminary stability studies. As the regulatory landscape for novel cosmetic actives grows more stringent, we’ve found that our investment in rigorous batch traceability and impurity screening pays dividends for everyone down the line.
On the production floor, manufacturing Pentahydroxy Tryptophan isn’t a routine run. The engineered reactors and controlled crystallization equipment stem from our early days working with hydroxyl-rich amino acids that posed challenges for classical synthetic setups. Equipment selection was shaped as much by trial as by textbook. An early run taught us the importance of tight temperature control to avoid side reactions that eat away at yield. Small shifts in solvent profile sometimes meant the difference between crisp crystals and a gummy suspension that clogged filters by mid-afternoon.
We took those lessons and built them into current SOPs, modifying stir speeds and reagent addition rates based on real process data. Our approach to process validation centers around closing the loop between lab data and real-time production decisions. Production managers sit in daily meetings with analytical and R&D staff. They swap notes on the day’s batch performance and push incremental process improvements. The result delivers not only specifications on paper, but consistent outcomes on the floor—which translates to reliable material in our customers’ hands.
External audits and internal documentation keep everyone sharp. We’ve welcomed input from regulatory consultants and outside partners, so the manufacturing backbone behind Pentahydroxy Tryptophan remains robust against both compliance review and practical use case adaptation. With every process tweak, we revisit raw material suppliers and assess cleaning protocols, aiming to prevent drift in impurity profiles that could frustrate end users.
Decades of hands-on work with niche biomolecules shaped how we prioritize and check for quality. This doesn’t come from chasing a marketable claim—it stems from feedback loops developed through trial runs on end-user equipment. In our experience, users flag inconsistencies much faster than QC paperwork ever will. Our teams spend time reviewing not just in-house analytics, but field reports and troubleshooting requests so we maintain that cycle of attention. In the early days, feedback delivered by frustrated chemists pushed us to isolate a trace oxidant contaminant that the standard spec didn’t flag but that ruined an entire run downstream. Fixing that demanded both humility and technical skill.
Since then, we’ve built out regular process verification, not just for regulatory reasons, but to shave risk out of every batch. Analysts dissect reaction signatures using NMR, trace elements by ICP-MS, and run accelerated stability protocols outside of standard storage conditions. We find that routine stress testing—exposing samples to repeated freeze-thaw cycles and elevated humidity—yields insights into long-term reliability. Batch to batch, operators check for both documented criteria and the subtle cues learned from years working with this chemistry.
Routine review meetings keep every process improvement iterative. Senior chemists, production leads, and quality assurance staff come together to vet unexpected results and chase down root causes of variability. Once, a batch drifted from usual granulation profiles. It triggered an impromptu meeting across three departments. The issue traced to a modification in cleaning procedure—something overlooked during a scheduled plant upgrade. Addressing the problem involved revisiting training protocols and adjusting checklists.
From day one, our site learned the value of direct handling experience. Pentahydroxy Tryptophan doesn’t pose the same hazards as many organics, yet our line operators wear full PPE and stick to established handling protocols. Years of monitoring demonstrated that many risks come not just from the product, but from cumulative exposures, cleaning compounds, and the hustle of a busy line. Each transfer, filtration, or packaging step follows documented routines aimed at limiting airborne dust and unintentional contact. We found protective eyewear and gloves made sense even for apparently mild materials.
Routine safety audits at our facility catch real-world short-cuts that creep in over time. Team members are trained to call out near-misses and minor spills, recognizing that small issues often precede larger incidents. In our work with customers, we share those lessons, circulating updated MSDS and safe-handling bulletins as process improvements show results. In one case, a simple suggestion—using a lower-velocity air stream during powder transfer—helped a downstream partner reduce airborne particulate by over 40%. The same lesson made its way back into our own SOPs.
The push for sustainable raw materials puts manufacturers like us in the spotlight. Sourcing high-purity starting materials for a molecule with five hydroxyl groups means making careful choices between cost, reliability, and environmental impact. Over the years, we’ve benchmarked plant-derived precursors as well as synthetic, selecting for the lowest impurity profile and highest reproducibility. Cost pressures in the specialty chemical market sometimes tempt a race to the bottom, yet we’ve found that cutting corners on precursor quality carries a steeper price in lost batches and dissatisfied users.
In recent years, regulatory changes have forced a closer look at every reagent and process stream. Our production managers work with suppliers who provide traceable sourcing and environmental transparency. We avoid uncontrolled waste streams by recycling solvents whenever feasible, and have invested in a closed-loop water system for our wash steps. We monitor all effluent, not simply for compliance, but as part of our own resource management plans. Ironically, the shift toward greener operations often saves both money and effort over time. A water recycling upgrade paid for itself quickly, and now features in our plant tour for visiting customers and partners.
This approach to sustainability not only stands up to regulatory reviews, but it aligns with the demands from some of the world’s most innovative biotech and materials developers. Pressure from those partners—including major research institutes and blue-chip materials companies—has sharpened our commitment to environmental stewardship. That attitude reflects in the pricing and documentation, making plain where every input comes from, and what happens after each batch is produced.
Manufacturers often talk about “partnering” with their customers, but in our experience, it means responding quickly when batches don’t perform as expected or delivery schedules shift. Pentahydroxy Tryptophan has proven itself in both core research and scaled-up production, because we keep two-way communication open at every step. One academic partner flagged an unexpected crystallization issue during initial formulation work. We worked through the details, invited their team to visit our facility, and scheduled side-by-side runs until the solution materialized. That experience surfaced process modifications that now benefit every batch.
We regularly host open feedback calls with our largest users, as well as new applicants hoping to push Pentahydroxy Tryptophan in novel directions. Instead of hiding process details, we show our technical approach, share batch records, and discuss potential limitations. This transparency built trust—critical in fields where a single failed batch disrupts not just lab schedules but multimillion-dollar bioprocessing projects.
On a practical level, that means not just answering emails about specifications, but sending quick samples so end users can prove protocol compatibility before a bulk order. We never shy away from requests for atypical granulation or moisture profiles, either. Some partners working in high-sensitivity analytical methods require dry, free-flowing powder; others want just enough residual moisture to simplify dissolution steps. Each comes with tradeoffs and tweaks, and we’re open about both the limits and creative opportunities those bring.
Pentahydroxy Tryptophan continues to show up in patent filings, peer-reviewed articles, and production pipelines that didn’t exist five years ago. Living through this surge means seeing incremental changes matter—regular tweaks to process, documentation, and logistics as the market matures. We stay in touch with academic and industry researchers through joint-development projects and conference appearances, looking for early signs where Pentahydroxy Tryptophan can power new discoveries.
One recent case involved a photobiology lab optimizing new protein markers. Our technical group worked over several months to modify the purification protocol, cutting unintended side-reactivity that hampered earlier attempts. That direct interaction created value both ways—our staff learned about emerging analytical needs, while the lab partner advanced their work on a foundation of reliable material.
We don’t see success as hitting a static purity number or pushing out bulk lots at any cost. The real test comes with seeing finished research papers and scaled-up products that rely on our process consistency and willingness to adapt. Every gram of Pentahydroxy Tryptophan on the market carries the legacy of hands-on manufacturing experience and hard-won process lessons, shaped by years in the field and evolving alongside our customer community.
Pentahydroxy Tryptophan rewards those who invest in a strong manufacturing foundation. From early process hiccups to the rhythm of safe and reliable production, our approach draws on tangible, real-world experience. Each step reflects both a commitment to scientific rigor and a deep appreciation for the challenges researchers and producers face. As expectations for specialized chemicals sharpen, and as regulatory and sustainability benchmarks tighten, proven experience and open lines of communication shape who succeeds. Day by day, batch by batch, we remain focused on delivering a product that earns trust—and that helps advance research and industry alike.